2-Acryloylamino-3-methyl-butyramide | 24214-02-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-Acryloylamino-3-methyl-butyramide
• 英文别名: 3-Methyl-2-(prop-2-enoylamino)butanamide
• CAS: 24214-02-6
• 化学式: C₈H₁₄N₂O₂
• 分子量: 170.211
• InChiKey: DLHITURSJUTRKN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  72.2
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• Diffusion control layers in diffusion transfer photographic products
  申请人：POLAROID CORPORATION

  公开号：EP0115053A2

  公开（公告）日：1984-08-08

  Polymers comprising recurring units having cyclic β-elimination moieties capable of undergoing β-elimination in an alkaline environment and are disclosed for use in diffusion control layers in diffusion transfer photographic products.

  本发明公开了包含循环单元的聚合物，这些循环单元具有能够在碱性环境中进行 β-消除的环状分子，可用于扩散转移照相产品中的扩散控制层。
• Beta-eliminating polymers for diffusion control in photographic products
  申请人：POLAROID CORPORATION

  公开号：EP0115054A2

  公开（公告）日：1984-08-08

  Polymerizable monomeric carbamates are disclosed. Polymers comprising recurring units from such carbamates undergo β-elimination in an alkaline environment and are useful in diffusion control layers in diffusion transfer photographic products.

  本发明公开了可聚合的单体氨基甲酸酯。由这种氨基甲酸酯的重复单元组成的聚合物在碱性环境中会发生β-消除反应，可用于扩散转移照相产品中的扩散控制层。
• Polymeric pyridinium ylide and products from same
  申请人：POLAROID CORPORATION

  公开号：EP0164100A2

  公开（公告）日：1985-12-11

  Polymers containing pyridinium ylide moieties are subjected to actinic irradiation to convert the pyridinium ylide moieties to water-insoluble or hydrophobic N-acyl-diazepine polymers. The polymeric pyridinium ylides can be used for the waterproofing or hydrophobization of surfaces and for the production of printing plates, photoresists, printed circuit boards and the like.

  含有吡啶鎓酰基的聚合物经过阳极辐照后，吡啶鎓酰基会转化为不溶于水或疏水的 N-酰基二氮杂卓聚合物。这种聚合吡啶鎓酰化物可用于表面防水或疏水，也可用于生产印刷板、光刻胶、印刷电路板等。
• INHIBITOR OF BRUTON TYROSINE KINASE
  申请人：BEIJING RECIPROCAPHARMACEUTICALS CO., LTD.

  公开号：US20220017484A1

  公开（公告）日：2022-01-20

  Disclosed herein is a compound of Formula (I) with a Btk inhibitory activity, wherein all the variables are as defined herein. The compound can be used for the treatment of diseases such as autoimmune diseases, xenogeneic immune diseases, cancers or thromboembolic diseases. Also disclosed is a pharmaceutical composition comprising a compound of Formula (I). Further provided is a compound capable of inhibiting the activity of Bruton's tyrosine kinase by covalent binding.
• US4288523A
  申请人：——

  公开号：US4288523A

  公开（公告）日：1981-09-08